Results 21 to 30 of about 52,947 (295)

Fluoxetine reduces murine graft-versus-host disease by induction of T cell immunosuppression [PDF]

open access: yes, 2013
Serotonin reuptake inhibitors (SRIs) are widely used drugs in the treatment of depression and anxiety disorders. Although SRIs are generally regarded as safe drugs with relatively few side effects, literature suggests that high concentrations of SRIs may
Billiau, An D   +6 more
core   +17 more sources

Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism

open access: yesEJNMMI Research, 2023
Background The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson’s disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we ...
Thomas E. H. Justesen   +4 more
doaj   +1 more source

Peripartal treatment with low‐dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone

open access: yesPhysiological Reports, 2022
Women mobilize up to 10% of their bone mass during lactation to provide milk calcium. About 8%–13% of mothers use selective serotonin reuptake inhibitors (SSRI) to treat peripartum depression, but SSRIs independently decrease bone mass.
Celeste M. Sheftel   +10 more
doaj   +1 more source

Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia

open access: yesPharmacology Research & Perspectives, 2023
Augmentation of antipsychotic treatment with antidepressants represents a common and beneficial treatment strategy in patients suffering from schizophrenia. Combining clozapine and the selective serotonin reuptake inhibitor (SSRI) sertraline represents a
Arnim Johannes Gaebler   +6 more
doaj   +1 more source

Pharmacogenetic Testing and Therapeutic Drug Monitoring Of Sertraline at a Residential Treatment Center for Children and Adolescents: A Pilot Study

open access: yesINNOVATIONS in Pharmacy, 2022
Background: Sertraline is commonly prescribed to children for the treatment of anxiety and major depressive disorder and is metabolized in part by CYP2C19. While dosing recommendations based on CYP2C19 genotype exist, there is sparse data in children on
Katelyn France   +2 more
doaj   +1 more source

SERTRALINE

open access: yesJournal of Prescribing Practice, 2021
In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #sertraline
openaire   +1 more source

The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products [PDF]

open access: yes, 2020
Many patients are not aware that natural products such as fruit juices or plant infusions can cause significant interactions with several drugs, some of which can be dangerous, especially when the medical treatment is for neurological or psychiatric ...
Bacinschi, Nicolae   +6 more
core   +2 more sources

Pharmacogenomic testing and its future in community pharmacy [PDF]

open access: yes, 2020
Although it is common to see pharmacogenomic testing used North America and Australia, it is not yet part of practice in the UK. With the promise of genomic screening becoming part of the NHS, pharmacists must equip themselves with a knowledge of how the
Wright, David, Youssef, Essra
core   +1 more source

Reversible Complete Heart Block in a Pregnant Woman Related to Sertraline TreatmentNovel Teaching Points

open access: yesCJC Open, 2022
Complete heart block (CHB) is a serious condition, usually affecting older patients. We report a case of CHB in a 31-year-old pregnant woman treated with sertraline in whom atrioventricular (AV) conduction normalized after discontinuation of sertraline ...
Frederik Cosedis Enevoldsen, MBBS   +2 more
doaj   +1 more source

Treatment for depression following mild traumatic brain injury in adults: A meta-analysis [PDF]

open access: yes, 2013
Primary objective: Development of depression after TBI is linked to poorer outcomes. The aim of this manuscript is to review evidence for the effectiveness of current treatments.
Barker-Collo, Suzanne   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy